Search

Your search keyword '"Granito Alessandro"' showing total 564 results

Search Constraints

Start Over You searched for: Author "Granito Alessandro" Remove constraint Author: "Granito Alessandro"
564 results on '"Granito Alessandro"'

Search Results

1. Hypoalbuminemia and Risk of Portal Vein Thrombosis in Cirrhosis

2. Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib

4. Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care

5. Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma

7. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

8. THU-472-YI Sorafenib as a second-line treatment after failure of Atezolizumab/Bevacizumab

9. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

10. Exploring Total Immunoglobulin A's Impact on Non-Biopsy Diagnosis of Celiac Disease: Implications for Diagnostic Accuracy.

11. Easy recognition and high autoimmune hepatitis specificity of smooth muscle antibodies giving an actin microfilament immunofluorescent pattern on embryonal vascular smooth muscle cells.

12. Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib.

13. Impact of Sarcopenia on the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib

14. Identification of Regorafenib Prognostic Index (REP Index) via Recursive Partitioning Analysis in Patients with Advanced Hepatocellular Carcinoma Receiving Systemic Treatment: A Real-World Multi-Institutional Experience

15. Assessing the impact of COVID-19 on liver cancer management (CERO-19)

17. Immunophenotyping: a promising non-invasive approach to predict response to atezolizumab-bevacizumab in advanced hepatocellular carcinoma

18. Moderni aspetti di semeiotica medica. Interpretazione clinica di segni e sintomi ed elementi di diagnosi differenziale

19. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy

20. Genetic, Immunological, Dietary, Gut Microbiota, and Environmental Determinants of Osteoporosis in the Course of Celiac Disease: Which Factor Plays the First Violin in This Orchestra?

21. Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

26. From an understanding of etiopathogenesis to novel therapies--what is new in the treatment of celiac disease?

31. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs

32. Prognostic impact of metastatic site in patients receiving first-line sorafenib therapy for advanced hepatocellular carcinoma

35. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

36. Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease Patients.

37. Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

39. Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma

41. Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma

45. Real-world dosing of regorafenib in patients with unresectable hepatocellular carcinoma (uHCC): Final analysis of the prospective, observational REFINE study.

46. COVID-19: Has the Liver Been Spared?

47. Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis

50. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

Catalog

Books, media, physical & digital resources